HLA-B27 rats develop osteopaenia through increased bone resorption without any change in bone formation.
Osteopaenia is a common complication of inflammatory bowel diseases (IBD). However, the mechanisms of bone loss are still the subject of debate. The aims of this study were to investigate bone loss in HLA-B27 transgenic rats, a spontaneous model of colitis and to compare the results provided by the usual markers of bone remodelling and by direct measurement of bone protein synthesis. Systemic inflammation was evaluated in HLA-B27 rats and control rats from 18 to 27 months of age. Then bone mineral density, femoral failure load, biochemical markers of bone remodelling and protein synthesis in tibial epiphysis were measured. Bone mineral density was lower in HLA-B27 rats than in controls. Plasma osteocalcin, a marker of bone formation, and fractional protein synthesis rate in tibial epiphysis did not differ between the two groups of rats. In contrast, urinary excretion of deoxypyridinoline, a marker of bone resorption, was significantly increased in HLA-B27 rats. The present results indicate that bone fragility occurs in HLA-B27 rats and mainly results from an increase in bone resorption. Systemic inflammation may be the major cause of the disruption in bone remodelling homeostasis observed in this experimental model of human IBD.
Papet
I
I
INRA, Centre de Clermont-Ferrand-Theix, UMR 1019 Unite de Nutrition Humaine, F-63122 Saint-Genes-Champanelle, France. papet@clermont.inra.fr
El Yousfi
M
M
Godin
J P
JP
Mermoud
A F
AF
Davicco
M J
MJ
Coxam
V
V
Breuille
D
D
Obled
C
C
D000596:Amino Acids / Q000652:urine; D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000097:blood / Q000209:etiology* / Q000503:physiopathology / Q000652:urine; D016723:Bone Remodeling; D001862:Bone Resorption / Q000150:complications / Q000652:urine; D003092:Colitis / Q000150:complications / Q000235:genetics; D004195:Disease Models, Animal; D004838:Epiphyses / Q000378:metabolism; D005269:Femur / Q000503:physiopathology; D015796:HLA-B27 Antigen / Q000235:genetics / Q000378:metabolism*; D008297:Male; D015675:Osteocalcin / Q000097:blood; D010012:Osteogenesis; D014176:Protein Biosynthesis; D051381:Rats; D011916:Rats, Inbred F344; D055647:Rats, Transgenic; D013718:Tensile Strength; D013977:Tibia / Q000378:metabolism
D000596:Amino Acids; D015415:Biomarkers; D015796:HLA-B27 Antigen; D015675:Osteocalcin; C036020:deoxypyridinoline